http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-WO2016104647-A1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-39 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H15-26 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-18 |
| filingDate | 2015-12-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2017-10-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-WO2016104647-A1 |
| titleOfInvention | Glycoconjugate vaccine antigen and glycan introduction agent |
| abstract | Provided is a vaccine antigen in which a sugar chain containing galactose α1-3 galactose (Galα1-3Gal) is bound via a linker. The vaccine antigen is expressed by the following formula (2) L represents a linker containing at least a hydrocarbon unit, A represents an antigen, Z represents a bond between the linker and the antigen, and m represents an integer of 1 or more. ) It is comprised with the compound represented by these. The antigen is preferably a cancer cell, a component of a cancer cell, a cancer antigen or a cancer antigen peptide. |
| priorityDate | 2014-12-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 135.